Status : investigational


BI-K0376 is investigated for use/treatment in acne. BI-K0376 is a solid. It is under investigation by Pfizer and has gone through phase I of the clinical trails.


Investigated for use/treatment in acne.

Mechanism Of Action

BI-K0376 has a unique mode of action that makes it extremely selective against the bacteria responsible for acne, Propionibacterium acnes, including those that have become resistant to other antibiotic treatments, whilst sparing normal skin bacterial flora.

Chemical Classification


Organic Compounds

Organic Acids

Carboxylic Acids and Derivatives

Amino Acids, Peptides, and Analogues

Calculated Property

kind Value Source